Expert Insights On CGT Formulation
-
Building A Self-Driving Lab For LNP Development
7/20/2026
With commercially available components, MIT researchers built a platform that accelerates LNP process development, optimization, and autonomous manufacturing research.
-
Addressing The Particulate Challenge In Cell Therapy Products
7/15/2026
Cell therapy products challenge traditional particulate controls. One expert explains detection, mitigation, and contamination prevention.
-
Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
7/14/2026
This article highlights government-funded resources available to de-risk nanomedicines, reviews principles of immunotoxicity testing, and discusses emerging methodologies.
-
Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
6/29/2026
While circular RNA platforms can enhance protein expression, developing effective delivery strategies remains the key challenge to achieving therapeutic efficacy.
-
Why Improving Drug Delivery Remains A Major Opportunity In Oncology
6/12/2026
Engineered oncolytic viruses are emerging as a promising way to target tumors, deliver immune-stimulating payloads, and improve treatment of metastatic cancer.
-
Strategic Synthesis Of ASGCT And ASCO 2026
6/10/2026
The spring 2026 conference season made one thing obvious to those of us watching the data: the artisan era of ex vivo cellular manufacturing is finally receding.
-
Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease
5/19/2026
Autologous intradiscal therapy integrates delivery and biology into one system, highlighting the potential of cell therapies in complex, localized disease environments.
-
Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
5/4/2026
Optimized delivery technologies will be central to next-generation therapies, serving as key differentiators for both clinical efficacy and operational feasibility.
-
Delivery Strategy For Next-Gen Cardiac Gene Therapies
3/12/2026
As the field matures, the most transformative gene therapies in heart health are treating delivery not as an afterthought but as a fundamental principle.
-
Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors
3/5/2026
Intratumoral injection bypasses the tumor’s physical defenses entirely, killing cancer cells and creating a personalized immune response that destroys solid tumors.